Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K. Wells(Parker Institute for Cancer Immunotherapy), Elham Sherafat(Parker Institute for Cancer Immunotherapy), Christopher Morehouse, Hira Rizvi(Memorial Sloan Kettering Cancer Center), Dirk Jäger(German Cancer Research Center), Aly A. Khan(University of Chicago), Xengie Doan(Sage Bionetworks), Brandon W. Higgs(Parker Institute for Cancer Immunotherapy), Alphonsus H. C. Ng(Institute for Systems Biology), Arbel D. Tadmor(California Institute of Technology), Cristina Puig-Saus(APLA Health), Barbara Schrörs(Institute for Systems Biology), Marit M. van Buuren(The Netherlands Cancer Institute), David Gfeller(Ludwig Cancer Research), Christian Iseli(SIB Swiss Institute of Bioinformatics), Bjoern Peters(La Jolla Institute for Immunology), Arjun A. Rao(University of California, San Francisco), Patrice Manning(Parker Institute for Cancer Immunotherapy), Ana-Belén Blázquez(Icahn School of Medicine at Mount Sinai), Ana Mijalkovic Lazic(Parker Institute for Cancer Immunotherapy), William Chour(California Institute of Technology), John Sidney(La Jolla Institute for Immunology), Andrew J. Rech(Parker Institute for Cancer Immunotherapy), Ariella Sasson(Memorial Sloan Kettering Cancer Center), Katie M. Campbell(University of California, Los Angeles), Kristen K. Dang, Beata Berent-Maoz(Parker Institute for Cancer Immunotherapy), Daphne M. van Beek, Vanessa M. Hubbard-Lucey, Angela Frentzen(Parker Institute for Cancer Immunotherapy), David Balli, Brian J. Stevenson, Ekaterina Esaulova, Thomas Yu(Sage Bionetworks), Kathleen C. F. Sheehan(Washington University in St. Louis), Jesse M. Zaretsky(Washington University in St. Louis), Jia M. Chen(University of California, Los Angeles), David Haussler(Santa Cruz County Office of Education), Jeffrey P. Ward(Washington University in St. Louis), Bo Li(Union Hospital), Christopher A. Miller(Washington University in St. Louis), Bin Song(Washington University in St. Louis), Cornelis J.M. Melief(Leiden University), Andrew Lamb(Sage Bionetworks), Eduardo Cortes, Baikang Pei(University of California San Diego), Gabriela Steiner(Parker Institute for Cancer Immunotherapy), Amit A. Lugade(Roswell Park Comprehensive Cancer Center), Begonya Comin-Anduix(University of California, Los Angeles), Beatriz M. Carreno(California University of Pennsylvania)
Cited by 534
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes
|Genome Research|2005|4.3k
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
|New England Journal of Medicine|2016|3.1k